Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
Go back to Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study| (NYSE: RCUS) | Delayed: 25.73 +1.08 (4.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.65 | 52 Week High | $ | |||
| Open | $25.31 | 52 Week Low | $ | |||
| Day High | $25.82 | P/E | N/A | |||
| Day Low | $25.05 | EPS | $ | |||
| Volume | 619,534 | |||||
